Retraction
Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease
Paper Information
Record ID:
47172
Author(s):
Publication Date:
May 13, 2020
Retraction Date:
August 25, 2023
(2.2 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (89)
89
Total Citations27
Post-Retraction(30.3%)
62
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
5
Within 30 days
23
Within 1 year
0
After 2+ years
665
Days since retraction (latest)
Modulation of Macrophages Using Nanoformulations with Curcumin to Treat Inflammatory Diseases: A Concise Review
Huxiao Sun, Mengsi Zhan, Serge Mignani et al. (8 authors)
Pharmaceutics
Open Access
Published: Oct 2022
14 citations
14 citations
309 days before retraction
The impacts of curcumin on learning memory function in Alzheimer’s disease under the poly lactic-co-glycolic acid nanoparticle drug carrier
Hongmei Zeng, Lijun Xu, Yeqing Zou et al. (4 authors)
Applied Nanoscience
Published: Oct 2022
4 citations
4 citations
312 days before retraction
Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases
Debashish Paramanick, Veena Devi Singh, Vijay Kumar Singh
Journal of Controlled Release
Published: Oct 2022
31 citations
31 citations
323 days before retraction
Cell membrane-camouflaged PLGA biomimetic system for diverse biomedical application
Jingjing Yan, Weidong Fei, Qianqian Song et al. (8 authors)
Drug Delivery
Open Access
Published: Jul 2022
10 citations
10 citations
400 days before retraction
Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease
Yara Mashal, Hosam Gharib Abdelhady, Arun K. Iyer
Biomolecules
Open Access
Published: Jul 2022
14 citations
14 citations
403 days before retraction
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders
Маргарита Е. Неганова, Yulia Aleksandrova, Olga Sukocheva et al. (4 authors)
Seminars in Cancer Biology
Published: Jun 2022
31 citations
31 citations
421 days before retraction
Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings
Philippe Delbreil, Jean‐Michel Rabanel, Xavier Banquy et al. (4 authors)
Advanced Drug Delivery Reviews
Published: Jun 2022
18 citations
18 citations
430 days before retraction
Application of curcumin nanoformulations in Alzheimer’s disease: prevention, diagnosis and treatment
Hongqian Lv, Yan Wang, Xiaotong Yang et al. (5 authors)
Nutritional Neuroscience
Published: Jun 2022
29 citations
29 citations
440 days before retraction
The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases
Mehdi Farhoudi, Saeed Sadigh‐Eteghad, Javad Mahmoudi et al. (6 authors)
Current Pharmaceutical Design
Published: Jun 2022
9 citations
9 citations
442 days before retraction
Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform
Miguel Pinto, Vera Silva, Sandra Barreiro et al. (7 authors)
Ageing Research Reviews
Published: Jun 2022
58 citations
58 citations
449 days before retraction
Curcumin as a Holistic Treatment for Tau Pathology
Lovesha Sivanantharajah, Amritpal Mudher
Frontiers in Pharmacology
Open Access
Published: May 2022
11 citations
11 citations
463 days before retraction
Recent Progress in Red Blood Cells-Derived Particles as Novel Bioinspired Drug Delivery Systems: Challenges and Strategies for Clinical Translation
Antony Vincy, Sarmistha Mazumder, Amrita Amrita et al. (6 authors)
Frontiers in Chemistry
Open Access
Published: Apr 2022
27 citations
27 citations
485 days before retraction
“Drug‐Carrier” Synergy Therapy for Amyloid‐<i>β</i> Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly
Guochen Han, Kaiwen Bai, Xiaoyu Yang et al. (8 authors)
Advanced Science
Open Access
Published: Mar 2022
35 citations
35 citations
523 days before retraction
Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy
Yilong Xi, Yun Chen, Yi Jin et al. (12 authors)
Journal of Controlled Release
Published: Mar 2022
22 citations
22 citations
539 days before retraction
Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
Qing‐Qing Tao, Rong-Rong Lin, Yi-He Chen et al. (4 authors)
Aging and Disease
Open Access
Published: Jan 2022
15 citations
15 citations
601 days before retraction
Tau-targeting therapy in Alzheimer’s disease: critical advances and future opportunities
Yi Guo, Song Li, Linghui Zeng et al. (4 authors)
Ageing and Neurodegenerative Diseases
Open Access
Published: Jan 2022
41 citations
41 citations
601 days before retraction
Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease
Seong Lin Teoh, Ker Woon Choy, Kah-Hui Wong et al. (6 authors)
Current Neuropharmacology
Open Access
Published: Dec 2021
20 citations
20 citations
613 days before retraction
Recent studies of atomic‐resolution structures of tau protein and structure‐based inhibitors
Lili Zhu, Zhenyu Qian
Quantitative Biology
Open Access
Published: Dec 2021
10 citations
10 citations
617 days before retraction
Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations
Syed Nasir Abbas Bukhari
Current Drug Delivery
Published: Sep 2021
10 citations
10 citations
711 days before retraction
Nanotechnology-based drug delivery for central nervous system disorders
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tuong Kha Vo et al. (7 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Aug 2021
120 citations
120 citations
724 days before retraction
PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer’s Disease
Sanaz Keshavarz Shahbaz, Khadijeh Koushki, Thozhukat Sathyapalan et al. (5 authors)
Current Neuropharmacology
Open Access
Published: Aug 2021
30 citations
30 citations
730 days before retraction
Preparation, characterization of PLGA/chitosan nanoparticles as a delivery system for controlled release of DHA
Enchao Liu, Shenghan Zhao, Xiao Li et al. (5 authors)
International Journal of Biological Macromolecules
Published: Jun 2021
25 citations
25 citations
786 days before retraction
Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
Duygu Ege
Materials
Open Access
Published: Jun 2021
65 citations
65 citations
800 days before retraction
Alzheimer’s Disease: Innovative Therapeutic Approaches Based on Peptides and Nanoparticles
Isabela Ferreira Lima Mota, Larissa Silva de Lima, Bruna de Miranda Santana et al. (10 authors)
The Neuroscientist
Published: May 2021
10 citations
10 citations
826 days before retraction
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease
Qin Ouyang, Yingcai Meng, Wenhu Zhou et al. (6 authors)
Journal of drug targeting
Published: May 2021
24 citations
24 citations
834 days before retraction
Curcumin: Modern Applications for a Versatile Additive
Florentina Monica Raduly, Valentin Rădiţoiu, Alina Rădiţoiu et al. (4 authors)
Coatings
Open Access
Published: Apr 2021
48 citations
48 citations
849 days before retraction
Fabrication, characterization and properties of DHA-loaded nanoparticles based on zein and PLGA
Enchao Liu, Zhiwei Su, Chen Yang et al. (6 authors)
Food Chemistry
Published: Apr 2021
30 citations
30 citations
849 days before retraction
Advances in developing therapeutic strategies for Alzheimer's disease
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Thi Kim Oanh Nguyen et al. (5 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Apr 2021
84 citations
84 citations
851 days before retraction
Nanomedicine: A Promising Way to Manage Alzheimer’s Disease
Nazeer Hussain Khan, Maria Mir, Ebenezeri Erasto Ngowi et al. (13 authors)
Frontiers in Bioengineering and Biotechnology
Open Access
Published: Apr 2021
65 citations
65 citations
868 days before retraction
Catalytic nanozymes for central nervous system disease
Ke Chen, Si Sun, Junying Wang et al. (4 authors)
Coordination Chemistry Reviews
Published: Jan 2021
57 citations
57 citations
946 days before retraction
Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends
Huihui Zeng, Yujie Qi, Zheyu Zhang et al. (6 authors)
Chinese Chemical Letters
Published: Jan 2021
62 citations
62 citations
953 days before retraction
Microenvironment-tailored nanoassemblies for the diagnosis and therapy of neurodegenerative diseases
Liang Ee Low, Qiyue Wang, Ying Chen et al. (11 authors)
Nanoscale
Published: Jan 2021
6 citations
6 citations
966 days before retraction
Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles
Aixue Li, Yunan Zhao, Yixiu Li et al. (6 authors)
Drug Delivery
Open Access
Published: Jan 2021
104 citations
104 citations
966 days before retraction
Cepharanthine loaded nanoparticles coated with macrophage membranes for lung inflammation therapy
Caihong Lu, Jinpeng Zheng, Yaning Ding et al. (9 authors)
Drug Delivery
Open Access
Published: Jan 2021
30 citations
30 citations
966 days before retraction
Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology
Umair Shabbir, Momna Rubab, Akanksha Tyagi et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2020
89 citations
89 citations
971 days before retraction
Biomimetic nanoarchitecturing: A disguised attack on cancer cells
Adrija Jha, Ajinkya Nitin Nikam, Sanjay Kulkarni et al. (8 authors)
Journal of Controlled Release
Published: Dec 2020
38 citations
38 citations
990 days before retraction
Curcumin Formulations and Trials: What’s New in Neurological Diseases
Stella Gagliardi, Carlo Morasso, Polychronis Stivaktakis et al. (10 authors)
Molecules
Open Access
Published: Nov 2020
37 citations
37 citations
1010 days before retraction
Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations
Yana Zorkina, Olga Abramova, Valeria Ushakova et al. (9 authors)
Molecules
Open Access
Published: Nov 2020
108 citations
108 citations
1015 days before retraction
Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction
Wenqiao Qiu, Rong Pan, Yong Tang et al. (11 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Aug 2020
59 citations
59 citations
1115 days before retraction
Quick Stats
Total Citations:
89
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025